Literature DB >> 7058987

Bile acid composition and esophagitis after total gastrectomy.

M Matikainen, T Laatikainen, T Kalima, E Kivilaakso.   

Abstract

Ten patients who had undergone total or subtotal gastrectomy for carcinoma 1 to 8 years earlier were evaluated in terms of subjective symptoms, endoscopy and the presence of bile in esophagojejunal aspirates obtained by direct aspiration during endoscopy. The concentrations of individual bile acids were determined by means of gas chromatography. Six of the patients had macroscopic esophagitis and all of them also had bile in their aspirate. The remaining four patients with normal esophageal mucosa did not have positive specimens. Neither did the total bile acid concentration nor any of the individual bile acids, regardless of whether they were free or conjugated, correlate with the severity of symptoms or the degree of endoscopic esophagitis. Esophagitis healed in all three patients who underwent conversion of loop esophagojejunostomy to a long Roux-Y reconstruction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058987     DOI: 10.1016/0002-9610(82)90066-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium.

Authors:  H Kazumori; S Ishihara; M A K Rumi; Y Kadowaki; Y Kinoshita
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

2.  New technique for analysing conjugated bile acids in gastric juice.

Authors:  D C Gotley; A P Morgan; M J Cooper
Journal:  J Clin Pathol       Date:  1990-11       Impact factor: 3.411

3.  Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity.

Authors:  D Nehra; P Howell; C P Williams; J K Pye; J Beynon
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 4.  Alkaline reflux oesophagitis.

Authors:  D L Stoker; J G Williams
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.